-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The Production Process of (±)-Orphenadrine: An Overview of Chemical Industry
Orphenadrine is a pharmaceutical drug that is primarily used to treat symptoms of Parkinson's disease, such as tremors and stiffness.
The drug is a synthetic compound that is derived from a natural substance called strychnine, which is obtained from the seeds of the Strychnine tree.
The production process of (±)-orphenadrine involves several steps, including the synthesis of the drug's starting material, the isolation and purification of the drug, and the formulation and packaging of the final product.
The synthesis of the starting material for the production of (±)-orphenadrine involves the use of several chemical reactions.
The synthesis starts with the conversion of spermine, a naturally occurring compound found in small amounts in many animal tissues, into spermine hydrochloride.
This is followed by a series of chemical reactions that result in the formation of the starting material for the production of (±)-orphenadrine.
The synthesis of the starting material is a crucial step in the production process, as it determines the quality and purity of the final product.
Once the starting material has been synthesized, it is isolated and purified through a series of chromatographic techniques.
The first step in the purification process is gel filtration, which separates the starting material from other impurities based on size.
The purified starting material is then subjected to high-performance liquid chromatography (HPLC), which separates the starting material based on its chemical properties.
This results in the isolation of the pure starting material, which is then used in the next step of the production process.
The isolation and purification of (±)-orphenadrine is a critical step in the production process, as it ensures that the final product is safe and effective.
The HPLC method used to purify the starting material is highly efficient and results in a product that is of a high purity.
This is essential for the drug to be effective in treating the symptoms of Parkinson's disease.
Once the starting material has been purified, it is combined with other chemicals to form the final product, (±)-orphenadrine.
This involves the use of